Lower esophageal sphincter and gastric acid response to intravenous infusions of synthetic human gastrin I heptadecapeptide
- PMID: 955342
Lower esophageal sphincter and gastric acid response to intravenous infusions of synthetic human gastrin I heptadecapeptide
Abstract
Human gastrin I heptadecapeptide was administered by constant intravenous infusion to 7 adult male volunteers without gastrointestinal disease, and serum gastrin concentrations and responses of the lower esophageal sphincter (LES) pressure and gastric acid output were measured and compared. Significant responses in LES pressure were found at gastrin infusion rates which produced submaximal gastric acid output. These LES pressure responses were quantitatively smaller than those occurring concomitantly with similar total immunoreactive gastrin levels evoked by administration of a protein meal in the same subjects. These observations suggest that, although increases in serum gastrin concentrations may contribute to increases in LES pressure seen under physiological conditions after feeding, the increase in LES pressure produced by feeding cannot be explained exclusively on the basis of endogenous gastrin release.
Similar articles
-
Effect of continuous infusion of pentagastrin on lower esophageal sphincter pressure and gastric acid secretion in normal subjects.J Clin Invest. 1975 Jul;56(1):218-25. doi: 10.1172/JCI108070. J Clin Invest. 1975. PMID: 1141433 Free PMC article.
-
Is gastrin a major determinant of basal lower esophageal sphincter pressure? A double-blind controlled study using high titer gastrin antiserum.J Clin Invest. 1976 Feb;57(2):291-300. doi: 10.1172/JCI108280. J Clin Invest. 1976. PMID: 1254724 Free PMC article. Clinical Trial.
-
Effect of somatostatin on lower esophageal sphincter (les) pressure and serum gastrin in normal and achalasic subjects.Horm Metab Res. 1982 Jan;14(1):26-8. doi: 10.1055/s-2007-1018911. Horm Metab Res. 1982. PMID: 6120888
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
[Significance of gastrin in gastric juice secretion].Dtsch Med Wochenschr. 1966 Aug 26;91(34):1506-12. doi: 10.1055/s-0028-1111546. Dtsch Med Wochenschr. 1966. PMID: 5330426 Review. German. No abstract available.
Cited by
-
Effect of human gastrin infusion on gastric potential difference in man.Dig Dis Sci. 1980 Nov;25(11):865-8. doi: 10.1007/BF01338529. Dig Dis Sci. 1980. PMID: 7438958
-
Serum gastrin in health and disease.Am J Dig Dis. 1977 Aug;22(8):712-6. doi: 10.1007/BF01078351. Am J Dig Dis. 1977. PMID: 889602
-
Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man.Gut. 1980 Apr;21(4):299-304. doi: 10.1136/gut.21.4.299. Gut. 1980. PMID: 7429291 Free PMC article.
-
Effect of gastrin-17 on lower esophageal sphincter characteristics in man.Dig Dis Sci. 1997 Dec;42(12):2547-51. doi: 10.1023/a:1018872814428. Dig Dis Sci. 1997. PMID: 9440634 Clinical Trial.
-
Lower oesophageal sphincter response to intravenous infusions of pentagastrin in normal subjects, antrectomised and achalasic patients.Gut. 1978 Dec;19(12):1121-4. doi: 10.1136/gut.19.12.1121. Gut. 1978. PMID: 744497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources